Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-19-025087
Filing Date
2019-07-17
Accepted
2019-07-16 20:35:09
Documents
8
Period of Report
2019-07-16

Document Format Files

Seq Description Document Type Size
1 6-K meso-6k_20190715.htm 6-K 26976
2 EX-99.1 meso-ex991_6.htm EX-99.1 203377
3 EX-99.2 meso-ex992_7.htm EX-99.2 44498
4 GRAPHIC ggiq30qirivf000001.jpg GRAPHIC 1430
5 GRAPHIC goijv53kfiy2000004.jpg GRAPHIC 260379
6 GRAPHIC goijv53kfiy2000001.jpg GRAPHIC 416188
7 GRAPHIC goijv53kfiy2000003.jpg GRAPHIC 94425
8 GRAPHIC goijv53kfiy2000002.jpg GRAPHIC 12606
  Complete submission text file 0001564590-19-025087.txt   1357559
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 19958108
SIC: 2836 Biological Products, (No Diagnostic Substances)